Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Menopause

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Hormonal Regulation of the Menstrual Cycle

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sleep-light interventions that shift melatonin rhythms earlier improve perimenopausal and postmenopausal depression: preliminary findings.

Menopause (New York, N.Y.)·2023

Same author

Critically-timed sleep+light interventions differentially improve mood in pregnancy vs. postpartum depression by shifting melatonin rhythms.

Journal of affective disorders·2022

Same author

A 1-week sleep and light intervention improves mood in premenstrual dysphoric disorder in association with shifting melatonin offset time earlier.

Archives of women's mental health·2022

Same author

Depressive history as a major predictor of postmenopausal depressive symptoms.

Menopause (New York, N.Y.)·2022

Same author

Estradiol fluctuations and depressive history as risk factors for menopausal depression.

Menopause (New York, N.Y.)·2021

Same author

Towards improving recognition and management of perimenopausal depression.

Menopause (New York, N.Y.)·2020

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Optimal management of perimenopausal depression.

Barbara L Parry¹

¹Department of Psychiatry, University of California, San Diego, USA.

International Journal of Women'S Health

|November 13, 2010

Summary

Perimenopause increases depression risk, impacting overall health. Combining antidepressants with estrogen shows promise for treating menopausal depression, alongside psychosocial support.

Area of Science:

Reproductive Psychiatry
Women's Health
Endocrinology

Background:

Perimenopause is a critical period for new or recurring major depression in women.
Untreated depression during this phase elevates risks for sleep disorders, cardiovascular disease, diabetes, and osteoporosis.
Estrogen replacement therapy may be beneficial as adjunctive treatment for refractory perimenopausal depression.

Purpose of the Study:

To review the role of hormonal changes during perimenopause in the onset and recurrence of major depression.
To evaluate the efficacy of various antidepressant treatments, including hormonal therapy, for perimenopausal depression.
To highlight the importance of a holistic approach to managing perimenopausal depression.

Main Methods:

Literature review of studies on perimenopausal depression, antidepressant efficacy, and hormonal treatments.

Keywords:

depression management menopause

Related Experiment Videos

Last Updated: Jun 6, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Analysis of the effects of estrogen and progesterone on mood and vasomotor symptoms.

Comparison of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) with or without estrogen therapy.

Main Results:

Estrogen replacement may enhance antidepressant effects and improve vasomotor symptoms, though progesterone may antagonize estrogen's benefits.
Estrogen alone may benefit some women with less severe symptoms but typically does not induce remission of major depression.
Combination therapy with SSRIs and estrogen often yields better mood improvement than either treatment alone; SNRIs appear effective without added estrogen.

Conclusions:

Optimal management of perimenopausal depression requires a multifaceted approach, including antidepressant medication, hormonal therapy when indicated, and attention to psychosocial and spiritual well-being.
Selective serotonin reuptake inhibitors (SSRIs) combined with estrogen are effective for perimenopausal depression.
Serotonin-norepinephrine reuptake inhibitors (SNRIs) offer an effective treatment option for menopausal depression without the need for estrogen augmentation.